|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 3/04 | (2006.01) |
| (11) | Number of the document | 3524261 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19163698.4 |
| Date of filing the European patent application | 2006-08-18 | |
| (97) | Date of publication of the European application | 2019-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
| (46) | Date of publication of the claims translation | 2024-04-10 |
| (30) | Number | Date | Country code |
| 77921606 P | 2006-03-03 | US | |
| 70960405 P | 2005-08-19 | US |
| (72) |
Fineman, Mark , US
Macconell, Leigh , US
Taylor, Kristin , US
|
| (73) |
Amylin Pharmaceuticals, LLC ,
9360 Towne Centre Drive, San Diego, CA 92121,
US
AstraZeneca Pharmaceuticals LP , 1800 Concord Pike, Wilmington, DE, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Eksendino naudojimas diabeto gydymui ir kūno svorio mažinimui |
| EXENDIN FOR USE IN TREATING DIABETES AND REDUCING BODY WEIGHT |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 20 | 347.00 EUR |